Compare Moderna, Inc. (MRNA) vs GeneDx Holdings Corp (WGS) Price & Performance

Moderna, Inc.Trade

GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs GeneDx Holdings Corp — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Moderna, Inc. is far larger — about 13.1× GeneDx Holdings Corp's market cap, and Moderna, Inc. is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.

	MRNA	WGS
Market Cap	$23.60B	$1.80B
Sector	Health	Technology
52-Week High	$81.80	$167.51
52-Week Low	$22.36	$34.51
Enterprise Value	$19.70B	$1.80B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 12 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

WGS

View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.